| Title |
Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial
|
|---|---|
| Published in |
Psychopharmacology, August 2012
|
| DOI | 10.1007/s00213-012-2848-0 |
| Pubmed ID | |
| Authors |
Lai Kuan Lee, Suzana Shahar, Ai-Vyrn Chin, Noor Aini Mohd Yusoff |
| Abstract |
Epidemiological studies have suggested a beneficial effect of fish oil supplementation in halting the initial progression of Alzheimer's disease. However, it remains unclear whether fish oil affects cognitive function in older people with mild cognitive impairment (MCI). |
X Demographics
The data shown below were collected from the profiles of 21 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 10% |
| United Kingdom | 2 | 10% |
| Australia | 2 | 10% |
| Canada | 2 | 10% |
| New Zealand | 1 | 5% |
| Unknown | 12 | 57% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 16 | 76% |
| Scientists | 2 | 10% |
| Practitioners (doctors, other healthcare professionals) | 2 | 10% |
| Science communicators (journalists, bloggers, editors) | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 306 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | <1% |
| Netherlands | 1 | <1% |
| Switzerland | 1 | <1% |
| Australia | 1 | <1% |
| Unknown | 301 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 54 | 18% |
| Student > Master | 48 | 16% |
| Researcher | 42 | 14% |
| Student > Ph. D. Student | 21 | 7% |
| Student > Doctoral Student | 17 | 6% |
| Other | 51 | 17% |
| Unknown | 73 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 52 | 17% |
| Nursing and Health Professions | 34 | 11% |
| Psychology | 34 | 11% |
| Agricultural and Biological Sciences | 22 | 7% |
| Neuroscience | 22 | 7% |
| Other | 61 | 20% |
| Unknown | 81 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 46. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 July 2021.
All research outputs
#904,344
of 25,382,035 outputs
Outputs from Psychopharmacology
#236
of 5,363 outputs
Outputs of similar age
#4,863
of 186,408 outputs
Outputs of similar age from Psychopharmacology
#4
of 44 outputs
Altmetric has tracked 25,382,035 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,363 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 186,408 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.